DOI QR코드

DOI QR Code

Economic Impact of Atopic Dermatitis in Korean Patients

  • Kim, Chulmin (Department of Family Medicine, School of Medicine, The Catholic University of Korea) ;
  • Park, Kui Young (Department of Dermatology, Chung-Ang University College of Medicine) ;
  • Ahn, Seohee (Department of Family Medicine, School of Medicine, The Catholic University of Korea) ;
  • Kim, Dong Ha (Department of Dermatology, Chung-Ang University College of Medicine) ;
  • Li, Kapsok (Department of Dermatology, Chung-Ang University College of Medicine) ;
  • Kim, Do Won (Department of Dermatology, Kyungpook National University School of Medicine) ;
  • Kim, Moon-Beom (Department of Dermatology, Pusan National University School of Medicine) ;
  • Jo, Sun-Jin (Department of Preventive Medicine, School of Medicine, The Catholic University of Korea) ;
  • Yim, Hyeon Woo (Department of Preventive Medicine, School of Medicine, The Catholic University of Korea) ;
  • Seo, Seong Jun (Department of Dermatology, Chung-Ang University College of Medicine)
  • Received : 2014.07.07
  • Accepted : 2014.10.12
  • Published : 2015.06.30

Abstract

Background: Atopic dermatitis is a global public health concern owing to its increasing prevalence and socioeconomic burden. However, few studies have assessed the economic impact of atopic dermatitis in Korea. Objective: We conducted a cost analysis of atopic dermatitis and evaluated its economic impacts on individual annual disease burden, quality of life, and changes in medical expenses with respect to changes in health related-quality of life. Methods: The cost analysis of atopic dermatitis was performed by reviewing the home accounting records of 32 patients. The economic impact of the disease was evaluated by analyzing questionnaires. To handle uncertainties, we compared the results with the data released by the Health Insurance Review & Assessment Board on medical costs claimed by healthcare facilities. Results: The direct cost of atopic dermatitis per patient during the 3-month study period was 541,280 Korean won (KRW), and expenditures on other atopic dermatitis-related products were 120,313 KRW. The extrapolated annual direct cost (including expenditures on other atopic dermatitis-related products) per patient was 2,646,372 KRW. The estimated annual indirect cost was 1,507,068 KRW. Thus, the annual cost of illness of atopic dermatitis (i.e., direct+indirect costs) was estimated to be 4,153,440 KRW. Conclusion: The annual total social cost of atopic dermatitis on a national level is estimated to be 5.8 trillion KRW.

Keywords

References

  1. Yu JS, Lee CJ, Lee HS, Kim J, Han Y, Ahn K, et al. Prevalence of atopic dermatitis in Korea: analysis by using national statistics. J Korean Med Sci 2012;27:681-685. https://doi.org/10.3346/jkms.2012.27.6.681
  2. Mancini AJ, Kaulback K, Chamlin SL. The socioeconomic impact of atopic dermatitis in the United States: a systematic review. Pediatr Dermatol 2008;25:1-6.
  3. Kang E, Shin H, Park H, Jo M, Kim N. A validation of Health Status Using EQ-5D. Korean J Health Econ Policy 2006:12:19-43.
  4. Kim CM. Health economics and outcomes research. Korean J Fam Med 2009;30:577-587. https://doi.org/10.4082/kjfm.2009.30.8.577
  5. Park MK, Park KY, Li K, Seo SJ, Hong CK. The short stature in atopic dermatitis patients: are atopic children really small for their age? Ann Dermatol 2013;25:23-27. https://doi.org/10.5021/ad.2013.25.1.23
  6. Ricci G, Bendandi B, Pagliara L, Patrizi A, Masi M. Atopic dermatitis in Italian children: evaluation of its economic impact. J Pediatr Health Care 2006;20:311-315. https://doi.org/10.1016/j.pedhc.2006.04.009
  7. Verboom P, Hakkaart-Van L, Sturkenboom M, De Zeeuw R, Menke H, Rutten F. The cost of atopic dermatitis in the Netherlands: an international comparison. Br J Dermatol 2002;147:716-724. https://doi.org/10.1046/j.1365-2133.2002.04964.x
  8. Gieler U, Hohmann M, Niemeier V, Kupfer J. Cost evaluation in atopic eczema. J Dermatol Treat 1999;10:S15-S20.
  9. Rathjen D, Thiele K, Staab D, Helberger C. Die Gesch ftsten Kosten Von Neurodermitis bei Kindern. Z Gezundheitswiss 2000;8:14-25. https://doi.org/10.1007/BF02956467
  10. Choi WJ, Ko JY, Kim JW, Lee KH, Park CW, Kim KH, et al. Prevalence and risk factors for atopic dermatitis: a cross-sectional study of 6,453 Korean preschool children. Acta Derm Venereol 2012;92:467-471. https://doi.org/10.2340/00015555-1252
  11. Suh DC, Sung J, Gause D, Raut M, Huang J, Choi IS. Economic burden of atopic manifestations in patients with atopic dermatitis--analysis of administrative claims. J Manag Care Pharm 2007;13:778-789.

Cited by

  1. Microbiome research in food allergy and atopic dermatitis vol.4, pp.6, 2015, https://doi.org/10.4168/aard.2016.4.6.389
  2. Awareness of Atopic Dermatitis and Attitudes toward Different Types of Medical Institutions for Its Treatment among Adult Patients and the Parents of Pediatric Patients: A Survey of 500 Participants vol.28, pp.6, 2015, https://doi.org/10.5021/ad.2016.28.6.725
  3. Clinical Diversity of Atopic Dermatitis: A Review of 5,000 Patients at a Single Institute vol.9, pp.2, 2015, https://doi.org/10.4168/aair.2017.9.2.158
  4. Health-related Quality of Life and Mental Health of Adults With Atopic Dermatitis vol.31, pp.5, 2015, https://doi.org/10.1016/j.apnu.2017.06.001
  5. Prevalence of Allergic Disease in Korean Adults: Results from the Korea National Health and Nutrition Examination Survey (2010–2012) vol.60, pp.10, 2017, https://doi.org/10.3342/kjorl-hns.2017.00185
  6. Economic Impact of Atopic Dermatitis in Adults: A Population-Based Study (IDEA Study) vol.109, pp.1, 2015, https://doi.org/10.1016/j.adengl.2017.11.020
  7. 학령전기 아토피피부염 아동 어머니의 스트레스 경험 vol.24, pp.2, 2015, https://doi.org/10.4094/chnr.2018.24.2.166
  8. Patient impact and economic burden of mild-to-moderate atopic dermatitis vol.34, pp.12, 2015, https://doi.org/10.1080/03007995.2018.1498329
  9. Review of health economic analyses in atopic dermatitis: how diverse is the literature? vol.19, pp.2, 2015, https://doi.org/10.1080/14737167.2019.1549491
  10. Burden of atopic dermatitis in Asia vol.46, pp.10, 2015, https://doi.org/10.1111/1346-8138.15048
  11. Understanding economic evidence for the prevention and treatment of atopic eczema vol.181, pp.4, 2015, https://doi.org/10.1111/bjd.17696
  12. Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy vol.20, pp.5, 2015, https://doi.org/10.1080/14737167.2020.1819793
  13. Anti-Inflammatory and Immune Modulatory Effects of Synbio-Glucan in an Atopic Dermatitis Mouse Model vol.13, pp.4, 2021, https://doi.org/10.3390/nu13041090
  14. Osthole Inhibits Expression of Genes Associated with Toll-like Receptor 2 Signaling Pathway in an Organotypic 3D Skin Model of Human Epidermis with Atopic Dermatitis vol.11, pp.1, 2015, https://doi.org/10.3390/cells11010088